The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
International Workshop on RSV Infection 2023
Related Enduring Materials
Sunday, 7 May 2023
Welcome
The International Workshop on RSV Infection 2023 took place as a hybrid meeting on 7 May 2023 in Lisbon, Portugal.
RSV is a leading cause of acute lower respiratory infection (ALRI) and respiratory mortality among young children globally. It is responsible for an estimated 3.6 million hospital admissions each year, increasing the burden of the epidemic on the healthcare systems and societies.
In 2019, RSV caused more than 100,000 deaths in children under the age of five years globally, with more than 45,000 occurring in children younger than six months old.
The disease burden in older children and adults is less studied. In the United States, an estimated 3-10 % of adults develop RSV-associated respiratory infection yearly, with 1-2 in 1000 patients admitted to hospital resulting in a 1-2 % case fatality rate.
Severe disease is associated with advanced age and underlying comorbidities. While young children often acquire RSV outside their homes, transmission within the household is a significant risk factor for the elderly. This transmission dynamic is integral to implementing prevention measures and future vaccination programs.
The COVID pandemic influenced the course of the RSV epidemic, with an initial major decrease followed by a subsequent rebound beyond the usual seasonality. This could have a significant impact on prevention strategies.
There is a crucial unmet need for knowledge exchange and discussion on preventing early childhood RSV-associated ALRI morbidity and mortality.
This program encompasses epidemiology, pathophysiology, system immunology, prevention in pediatrics and adults, vaccination during pregnancy, and treatment options in neonates.
Program Chairs 2023
General Information
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
- Pulmonologists
- Geriatric and palliative care experts
- Infectious disease clinicians, clinical virologists, intensivists, microbiologists,
epidemiologists
- Vaccine providers and their immunization practice teams
- Nurses and pharmacists
- Public health officials
- Researchers
- Community representatives
- Increasing knowledge on the prevention, diagnostic, clinical management, and surveillance of RSV in global healthcare settings;
- Strengthening capacity in the prevention, diagnostics, and management of RSV
- Reducing the existing health disparities globally by providing education on the most relevant RSV prevention, surveillance, and treatment-related topics to healthcare professionals from diverse world regions
- Identify accessible diagnostic and therapeutic options and relevant challenges for RSV
- Highlight the outpatient and inpatient clinical management and complications resulting from RSV infection
- Describe the latest advancement in the development of RSV prevention products and
discuss the implementation landscape
- Plan strategies to better prepare the healthcare system for the rollout and implementation of innovative preventive strategies
- Reflect on the lessons learned from RSV infection in terms of the emergence of variants,
surveillance, and preparedness
- Specify which surveillance and public health measures have been effective globally and in
low- and middle-income countries
Practical Information
Full Address:
Av. José Malhoa 8
1099-089
Lisboa
Portugal
https://vistos.mne.gov.pt/en/national-visas/general-information/who-needs-a-visa
The accommodation link will be provided at the registration confirmation.
Translation will not be provided.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration is free for all Regular Delegates*. A registration fee applies to other individuals.
Fees and Conditions
Regular Delegates* | Industry** | |
---|---|---|
Early Fee (payment before/on 28 February 2023) | Free Registration* | €1095 |
Standard Fee (payment before/on 30 April 2023) | Free Registration* | €1495 |
Onsite/Same Day Fee (Payment from 1 May 2023) | Free Registration* | €1695 |
Discounts | |
---|---|
Members of Endorsers | 25% Off Current Academia Fee |
Sponsors | Contact Secretariat |
*Free Registration is offered to the following participants: NGO Representatives, Advocates, Community Representatives, Policy Makers/ Government Representatives or Healthcare Professionals. Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV or other diseases.
**For virtual or in-person participation
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Access to all scientific sessions, including poster area
- Workshop pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on meeting days
For virtual attendees only:
- Access to all scientific sessions
- Digital workshop pack, including the program
IMPORTANT:
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Cancellation before/on 7 April 2023: 50% refund (minus an administration fee of €40)
- Cancellation after 7 April 2023: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 23 April 2023. A statement (email/letter) of cancellation must be sent to Virology Education.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@virology-education.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
Abstracts
- The International Workshop on RSV Infection 2023 accepts new original data as well as encored abstracts. All abstracts must focus on RSV and contain up-to-date information at the time of the conference.
-
Abstract submitters are encouraged to use person-first language in their abstracts. View our guidelines here
Abstracts can be submitted under the following categories:
• Epidemiology of RSV in Diverse Populations
• Management of Acute RSV and Acute Lower Respiratory Infection (ALRI) in Children and Adults
• Clinical Laboratory Testing for RSV
• Management of Acute Complications of RSV and ALRI
• Management of Post RSV and ALRI Chronic Respiratory Disease
• RSV and Underlying Conditions (Prematurity, Chronic Lung and Cardiovascular Disease, Immunosuppression, Neuromuscular Disease and other Comorbidities)
• Vaccines and Monoclonal Antibodies for the Prevention of RSV in Infants, Children, Pregnant People, and Older Adults
• Antiviral Therapies for the Treatment of RSV in Infants, Children, Pregnant People, and Older Adults
• Impact of RSV on Healthcare and the Society
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Note: For hybrid events, poster presenters are expected to attend onsite.
Posters need to meet the following dimensions A0 size (approx. 33" x 47") in portrait format.
Please display the number of your poster in the upper right corner of your poster.
In addition, you are welcome to make a short recording (max. 2 min) of your presentation with a few slides using PowerPoint. You can record this video directly from PowerPoint.
You need to upload your poster and short video on the Virtual Workshop Portal.
Your poster and the short video will be available on our website after the workshop days.
Once onsite:
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the workshop.
Pushpins and/or velcro will be provided.
RSV Infection 2023 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop!
A 25% discount on the academia registration fee is offered to members/employees of endorsers. Please reach out to your organization to obtain the applicable discount code.
If you would like your organization to endorse this workshop, please contact Christina Moustakaki at Christina.Moustakaki@amededu.com
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in RSV Infection.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Christina Moustakaki at Christina.Moustakaki@amededu.com or call +31 30 2307147.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.